Seguir
nabil saba
nabil saba
Professor and Vice Chair, Lynne and Howard Halpern Chair in Head and Neck Cancer Research
Dirección de correo verificada de emory.edu
Título
Citado por
Citado por
Año
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
New England Journal of Medicine 375 (19), 1856-1867, 2016
45052016
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by …
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
Oral oncology 81, 45-51, 2018
7212018
An update on larynx cancer
CE Steuer, M El‐Deiry, JR Parks, KA Higgins, NF Saba
CA: a cancer journal for clinicians 67 (1), 31-50, 2017
6602017
Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytes
AS Shet, O Aras, K Gupta, MJ Hass, DJ Rausch, N Saba, L Koopmeiners, ...
Blood 102 (7), 2678-2683, 2003
6462003
Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study
J Bauml, TY Seiwert, DG Pfister, F Worden, SV Liu, J Gilbert, NF Saba, ...
Journal of Clinical Oncology 35 (14), 1542, 2017
6372017
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related …
KJ Harrington, RL Ferris, G Blumenschein, AD Colevas, J Fayette, ...
The Lancet Oncology 18 (8), 1104-1115, 2017
3972017
Head and neck cancer
MD Mody, JW Rocco, SS Yom, RI Haddad, NF Saba
The Lancet 398 (10318), 2289-2299, 2021
3532021
Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973‐2007 surveillance, epidemiology, and end results data
CL Ellington, M Goodman, SA Kono, W Grist, T Wadsworth, AY Chen, ...
Cancer 118 (18), 4444-4451, 2012
3472012
Safety and efficacy of durvalumab with or without tremelimumab in patients with PD-L1–low/negative recurrent or metastatic HNSCC: the phase 2 CONDOR randomized clinical trial
LL Siu, C Even, R Mesía, E Remenar, A Daste, JP Delord, J Krauss, ...
JAMA oncology 5 (2), 195-203, 2019
2612019
Management of locally recurrent nasopharyngeal carcinoma
AWM Lee, WT Ng, JYW Chan, J Corry, A Mäkitie, WM Mendenhall, ...
Cancer treatment reviews 79, 101890, 2019
2432019
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009
B Ansa, M Goodman, K Ward, SA Kono, TK Owonikoko, K Higgins, ...
Cancer 119 (14), 2602-2610, 2013
2182013
Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer …
RL Ferris, Y Flamand, GS Weinstein, S Li, H Quon, R Mehra, JJ Garcia, ...
Journal of clinical oncology 40 (2), 138, 2022
1932022
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
P Strojan, JB Vermorken, JJ Beitler, NF Saba, M Haigentz Jr, P Bossi, ...
Head & neck 38 (S1), E2151-E2158, 2016
1882016
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer
CS Eberhardt, HT Kissick, MR Patel, MA Cardenas, N Prokhnevska, ...
Nature 597 (7875), 279-284, 2021
1762021
Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results …
NF Saba, M Goodman, K Ward, C Flowers, S Ramalingam, T Owonikoko, ...
Oncology 81 (1), 12-20, 2011
1572011
Defining HPV-specific B cell responses in patients with head and neck cancer
A Wieland, MR Patel, MA Cardenas, CS Eberhardt, WH Hudson, ...
Nature 597 (7875), 274-278, 2021
1432021
Nasal juvenile angiofibroma: Current perspectives with emphasis on management
F López, A Triantafyllou, CH Snyderman, JL Hunt, C Suárez, VJ Lund, ...
Head & neck 39 (5), 1033-1045, 2017
1392017
Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: efficacy and safety in CheckMate 141 by prior cetuximab use
RL Ferris, L Licitra, J Fayette, C Even, G Blumenschein Jr, KJ Harrington, ...
Clinical Cancer Research 25 (17), 5221-5230, 2019
1372019
High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant
N Saba, DM Sutton, HJ Ross, S Siu, RM Crump, A Keating, AK Stewart
Bone marrow transplantation 24 (8), 853-855, 1999
1261999
ACR Appropriateness Criteria® retreatment of recurrent head and neck cancer after prior definitive radiation: Expert panel on radiation oncology–head and neck cancer
MW McDonald, J Lawson, MK Garg, H Quon, JA Ridge, N Saba, ...
International Journal of Radiation Oncology* Biology* Physics 80 (5), 1292-1298, 2011
1252011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20